New York State Common Retirement Fund’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-640
Closed -$15.9K 3249
2024
Q2
$15.9K Buy
640
+86
+16% +$2.44K ﹤0.01% 3223
2024
Q1
$17.8K Sell
554
-40
-7% -$1.49K ﹤0.01% 3151
2023
Q4
$24.1K Sell
594
-196
-25% -$7.21K ﹤0.01% 3129
2023
Q3
$27.3K Sell
790
-68
-8% -$2.65K ﹤0.01% 3150
2023
Q2
$34.9K Buy
858
+250
+41% +$10.2K ﹤0.01% 3189
2023
Q1
$23.5K Buy
+608
New +$25K ﹤0.01% 3109
2020
Q3
Sell
-1,400
Closed -$276K 3229
2020
Q2
$276K Hold
1,400
﹤0.01% 2503
2020
Q1
$274K Hold
1,400
﹤0.01% 2307
2019
Q4
$290K Buy
+1,400
New +$259K ﹤0.01% 2556
2017
Q3
Sell
-2,173
Closed -$166K 3121
2017
Q2
$166K Buy
+2,173
New +$183K ﹤0.01% 2931
2017
Q1
Sell
-7,498
Closed -$481K 3147
2016
Q4
$481K Buy
+7,498
New +$461K ﹤0.01% 2386

Other funds holding LKFT

New York State Common Retirement Fund's LKFT Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2024, closing a stake of 640 shares — an estimated $15.9K sold.

New York State Common Retirement Fund first reported a position in LKFT in Q4 2016 and held it in 11 quarters. The position peaked at $481K in Q4 2016. 79 funds tracked by Wall St. Rank hold LKFT as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 640 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2024, an estimated $15.9K.
  • New York State Common Retirement Fund first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 11 quarters.
  • New York State Common Retirement Fund's Lakefront Biotherapeutics American Depositary Shares position peaked at $481K in Q4 2016.
  • 79 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.